- Clone:
- MP6-XT22
- Type of antibody:
- Primary antibodies
- Isotype:
- rat IgG1κ
- Applications:
- ICFC, FA Glossary
- Select a conjugate:
Related products for TNF-α Antibody, anti-mouse
Selected fluorochrome conjugated antibodies from Miltenyi Biotec were compared to commercially available hybridoma clones in flow cytometry analysis.
Flow cytometric comparison of different clones for TNF-α. Splenocytes from Balbc/c mice were stimulated with 50 ng/mL CD3 + 1 µg/mL CD28 for 2h, followed by an incubation with 1µg/mL brefeldin A for 4 hours. Cells were first stained with Viobility™ Fixable Dye followed by a suitable counterstaining. Cells were then fixed and permeabilized using the Inside Stain Set followed by intracellular staining with TNF-αantibodies. As a control, TNF-α antibody staining was omitted and cells were measured in the same channels. Flow cytometry was performed with the MACSQuant® Analyzer. Cell debris, dead cells, and cell doublets were excluded from the analysis based on scatter signals and Viobility 405/520 Fixable Dye fluorescence. No FcR Blocking Reagent was used. The recommended titers of respective antibodies from different suppliers were used.
Mouse tumor necrosis factor α (TNF-α) is secreted by macrophages, monocytes, neutrophils, CD4+ T cells, and NK cells. It has cytolytic activity against a range of tumor cells and is important in immune regulation. TNF-α binding to surface receptors elicits a wide array of biologic activities, including cytolysis and cytostasis of many tumor cell lines in vitro, hemorraghic necrosis of tumors in vivo, increased fibroblast proliferation, and enhanced chemotaxis and phagocytosis in neutrophils.
TNF, DIF, TNFSF2, Tnfsf1a
Technical specifications
To access a Certificate of Analysis (CoA) follow the link below and enter the specific lot of your product.
Should you wish to request additional documentation, such as a Safety Data Sheet (SDS) in other languages than English or Swedish, an SDS-replacement document, or a Certificate of Origin (CoO), please direct your inquiry to your local technical support team.
You have previously chosen International as your location.
What do you want to do?